Agios Pharmaceuticals Inc at Cowen Health Care Conference Transcript
Okay. Let's get a running start. Good morning. My name is Chris Shibutani, I'm a member of the Cowen Biotech Research Group. I am thrilled to present this next company, Agios Pharmaceuticals. We -- and our group always choose talks that we think will perform best throughout the year. In 2019, amongst those small mid-cap names, Agios was my pick. We also identify this company as one of the companies that really is on that cluster of companies that could become the next kind of generation of Genentech 2.0, so to speak. Companies that have some special secret sauce, the ability to take it to that next level. And really, kind of an outlook that can extend beyond to where the company could really grow and become one of the franchise player [within] biotech. We're thrilled to have us, the CFO, Andrew Hirsch; and Chief Scientific Officer, Scott Biller.
Andrew is going to kick off with some comments. Then I'll confuse them with questions shortly. Thanks.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
